Sponsored bills
Allows the synchronization of plan participants' medications. Requires plans, policies, contracts, or agreements that are offered by health insurers, mutual benefit societies, and health maintenance organizations and provide prescription drug benefits, to apply prorated daily cost-sharing rates for prescriptions dispensed by network pharmacies for less than a thirty-day supply. (HB2145 CD1)
Appropriates funds to the Department of Land and Natural Resources to provide assistance and supplemental funding to the National Wildlife Research Center of the U.S. Department of Agriculture to conduct pilot field studies to evaluate control tools, develop a control plan, and support other efforts to reduce the rose-ringed parakeet population on Kauai. (HB2081 CD1)
Amends the ethics training requirement for dentists in the continuing education program to be six hours of ethics training within the previous two years for each biennial renewal period. (SD1)
Establishes the Office of Medical Cannabis Control and Regulation in the Department of Health to regulate and administer the registration of qualifying patients and primary caregivers and medical cannabis dispensaries. Extends civil service exemptions for persons in civil service exempt positions prior to enactment of this measure who will transfer into the Office due to this measure. Extends interim rulemaking authority. Appropriates funds. (HB2742 CD1)
Appropriates moneys for youth suicide early intervention, prevention, and education initiatives in Maui county. (HB2169 CD1)
Amends the cesspool upgrade, conversion, or connection income tax credit pilot program by repealing the provision that restricts DOH from certifying more than two residential large capacity cesspools as qualified cesspools. (HB1802 CD1)
Establishes standards and criteria for reciprocity for qualifying out-of-state medical cannabis patients and caregivers including limitations, and safeguards. Authorizes extension of written certifications of a debilitating condition for up to three years for chronic conditions. Clarifies a dispensary licensee's right to retest marijuana or manufactured cannabis products for compliance with standards. Authorizes establishment of a bona fide provider-patient relationship via telehealth. Authorizes dispensing of devices that provide safe pulmonary administration of medical cannabis by dispensary licensees. Increases the allowable tetrahydrocannabinol limit for of certain manufactured cannabis products. Limits felony convictions that disqualify an individual from employment with a dispensary licensee. Establishes a working group to make recommendations regarding employment of qualifying patients and manufacture and dispensing of edible cannabis products. (HB2729 CD1)